Back to All

Integration Standardization and Diagnostics Oversight of Laboratory Testing

3 September, 2019

The September 2019 issue of The Journal of Molecular Diagnostics (JMDfeatures an editorial focusing on the standardization and diagnostics oversight of laboratory testing, and introduces the article entitled “Diagnostics Reform and Harmonization of Clinical Laboratory Testing” authored by thought leaders at Diaceutics and published in that month’s issue

To read the JMD editorial, click here:

To read the full article, authored by Jeff SchreierRobert Feeney, and Peter Keeling, click here: For a summary of the article, click here:

About Diaceutics

At Diaceutics we believe that every patient should get the precision medicine they deserve. We are a data analytics and end-to-end services provider enabled by DXRX - the world’s first Network solution for the development and commercialization of precision medicine diagnostics. 

Diaceutics has worked on every precision medicine brought to market and provides services to 36 of the world’s leading pharmaceutical companies. We have built the world’s largest repository of diagnostic testing data with a growing network of 2500 labs in 51 countries.

Public Relations & Investor Relations advisers

Alma PR
71-73 Carter Lane

Tel: +44 (0)20 3405 0205 or [email protected]

Caroline Forde
Robyn Fisher
Kieran Breheny